Glipizide Tablets

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Approval Status:

Approved September 1997

Specific Treatments:


Therapeutic Areas

Find Related Trials for The Following Conditions

General Information

The U.S. Food and Drug Administration has authorized Duramed Pharmaceuticals, Inc. to market Glipizide tablets, a treatment for diabetes, in the 5 mg and 10 mg strengths. The FDA granted Duramed's Glipizide tablets a therapeutic equivalency rating of AB, designating Duramed's Glipizide tablets as completely interchangeable with Glucotrol (R) tablets for all new and refill prescriptions.